Recomlyse | Overdosage | MIMS Thailand

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Overdosage

This product is highly specific for fibrinogen, but overdose may still result in a reduction in fibrinogen and other coagulation factors. In the event of overdose there may be an increased risk of bleeding. In most cases, physiological regeneration is sufficient to replenish these factors after discontinuation of treatment with Recomlyse. In case of severe prolonged bleeding, substitution therapy may be considered (plasma, fresh whole blood, platelets) and synthetic antifibrinolytic agents can be used if necessary.

Recomlyse Overdosage

tenecteplase

Manufacturer:

CSPC Pharma